vTv Therapeutics Inc.
VTVT | NASDAQ
$31.56
+$0.26 (+0.83%)
Sep 22, 2026, 11:14 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 1.02M | n/a | 2.02M | 4.01M | 6.41M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 11.02M |
Gross Profit | n/a | 1.02M | n/a | 2.02M | 4.01M | -4.6M |
Operating Income | -32.81M | -24.18M | -25.5M | -22.54M | -21.66M | -11.85M |
Interest Income | 1.87M | 1.57M | 472K | 352K | 1K | 12K |
Pretax Income | -31.08M | -22.61M | -25.97M | -24.87M | -17.62M | -12.8M |
Net Income | -26.97M | -18.46M | -20.25M | -19.16M | -12.99M | -8.5M |
Selling & General & Admin | 14.95M | 13.65M | 11.91M | 12.2M | 12.34M | 7.25M |
Research & Development | 17.86M | 11.55M | 13.6M | 12.36M | 13.32M | 11.02M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -11.02M |
Operating Expenses | 32.81M | 25.2M | 25.5M | 24.56M | 25.67M | 7.25M |
Interest Expense | 6K | n/a | 13K | 15K | 12K | 692K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.81M | 25.2M | 25.5M | 24.56M | 25.67M | 18.27M |
Income Tax Expense | n/a | 100K | n/a | 200K | 115K | n/a |
Shares Outstanding (Basic) | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M | 1.18M |
Shares Outstanding (Diluted) | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M | 1.18M |
EPS (Basic) | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 |
EPS (Diluted) | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 |
EBITDA | -31.06M | -22.52M | -25.86M | -24.77M | -17.52M | -12.02M |
EBIT | -31.07M | -22.61M | -25.95M | -24.86M | -17.6M | -12.11M |
Depreciation & Amortization | 16K | 89K | 90K | 92K | 89K | 94K |
Add to Watchlist
Select watchlists to add or remove VTVT